Tag: mRNA-vaccine

Oct 05, 2026

• cancer
• vaccine
• mRNA
• melanoma
• adjuvant-therapy
• keytruda
• moderna
• merck
• mRNA-vaccine
• neoantigen
• phase-3-trial

Oct 04, 2026

• oncology
• immunotherapy
• mRNA-vaccine
• melanoma
• adjuvant-therapy
• keytruda
• moderna
• merck
• immune-checkpoint-inhibitor
• pembrolizumab

Oct 04, 2026

• oncology
• immunotherapy
• mRNA-vaccine
• melanoma
• pembrolizumab
• keytruda
• moderna
• merck
• adjuvant-therapy
• pd-1-inhibitor

Oct 04, 2026

• personalized-medicine
• oncology
• mRNA-vaccine
• melanoma
• adjuvant-therapy
• immuno-oncology
• precision-medicine
• genomic-profiling
• targeted-therapy
• neoantigen

Oct 03, 2026

• oncology
• immunotherapy
• mRNA-vaccine
• melanoma
• adjuvant-therapy
• keytruda
• moderna
• merck
• personalized-medicine

Sep 26, 2026

• company
• pharmaceutical
• biotechnology
• oncology
• immunotherapy
• mRNA-vaccine
• healthcare
• merck
• keytruda